Ibrutinib in Treating Patients With Relapsed Hairy Cell Leukemia
Clinical trial NCT01841723 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT01841723
- Sponsor
- National Cancer Institute (NCI)
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2013-04-30
- Primary completion
- 2029-12-31
- Enrollment
- 44
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.